Cargando…

Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling

Despite its widespread use in oncology, the PET radiotracer (18)F-FDG is ineffective for improving early detection of pancreatic ductal adenocarcinoma (PDAC). An alternative strategy for early detection of pancreatic cancer involves visualization of high-grade pancreatic intraepithelial neoplasias (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knight, James C., Torres, Julia Baguña, Goldin, Robert, Mosley, Michael, Dias, Gemma M., Bravo, Luisa Contreras, Kersemans, Veerle, Allen, P. Danny, Mukherjee, Somnath, Smart, Sean, Cornelissen, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383084/ https://www.ncbi.nlm.nih.gov/pubmed/31862800 http://dx.doi.org/10.2967/jnumed.119.234708

Ejemplares similares

Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
por: Torres, Julia Baguña, et al.
Publicado: (2017)

Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
por: Torres, Julia Baguña, et al.
Publicado: (2020)

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours()()
por: Knight, James C., et al.
Publicado: (2019)

PET Imaging of PARP Expression Using (18)F-Olaparib
por: Wilson, Thomas C., et al.
Publicado: (2019)

Imaging DNA Damage Repair In Vivo After (177)Lu-DOTATATE Therapy
por: O’Neill, Edward, et al.
Publicado: (2020)

Immuno-imaging of ICAM-1 in tumours by SPECT
por: Mosley, Michael, et al.
Publicado: (2020)

Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
por: Elvina Xavier, Mary-Ann, et al.
Publicado: (2019)

Imaging PARP with [(18)F]rucaparib in pancreatic cancer models
por: Chan, Chung Ying, et al.
Publicado: (2022)

A Carbon-Fiber Sheet Resistor for MR-, CT-, SPECT-, and PET-Compatible Temperature Maintenance in Small Animals
por: Kersemans, Veerle, et al.
Publicado: (2019)

[(18)F]AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET Imaging
por: Guibbal, Florian, et al.
Publicado: (2020)

A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes
por: Veal, Mathew, et al.
Publicado: (2021)

Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
por: Kersemans, Veerle, et al.
Publicado: (2010)

(111)In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin
por: Cornelissen, Bart, et al.
Publicado: (2012)

Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture
por: Jiang, Yanyan, et al.
Publicado: (2015)

A simple, open and extensible gating Control unit for cardiac and respiratory synchronisation control in small animal MRI and demonstration of its robust performance in steady-state maintained CINE-MRI
por: Gilchrist, Stuart, et al.
Publicado: (2021)

A System-Agnostic, Adaptable and Extensible Animal Support Cradle System for Cardio-Respiratory-Synchronised, and Other, Multi-Modal Imaging of Small Animals
por: Kersemans, Veerle, et al.
Publicado: (2021)

An MRI-Compatible High Frequency AC Resistive Heating System for Homeothermic Maintenance in Small Animals
por: Gilchrist, Stuart, et al.
Publicado: (2016)

Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [(18)F]olaparib in mouse models of glioma
por: Chan, Chung Ying, et al.
Publicado: (2022)

Hypoxia Imaging Using PET and SPECT: The Effects of Anesthetic and Carrier Gas on [(64)Cu]-ATSM, [(99m)Tc]-HL91 and [(18)F]-FMISO Tumor Hypoxia Accumulation
por: Kersemans, Veerle, et al.
Publicado: (2011)

A resistive heating system for homeothermic maintenance in small animals
por: Kersemans, Veerle, et al.
Publicado: (2015)

Reduced respiratory motion artefact in constant TR multi-slice MRI of the mouse
por: Kinchesh, Paul, et al.
Publicado: (2019)

Imaging DNA damage response by γH2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome
por: O'Neill, Edward, et al.
Publicado: (2023)

Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
por: Lauder, Sarah Nicol, et al.
Publicado: (2020)

DNA damage repair mutations in pancreatic cancer– prognostic or predictive?
por: Hu, Ya-Fei, et al.
Publicado: (2023)

Imaging the DNA damage response with PET and SPECT
por: Knight, James C., et al.
Publicado: (2017)

Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
por: Thomas, Eloise, et al.
Publicado: (2019)

Translational molecular imaging in exocrine pancreatic cancer
por: Cornelissen, Bart, et al.
Publicado: (2018)

Improved detection of molecularly targeted iron oxide particles in mouse brain using B(0) field stabilised high resolution MRI
por: Gilchrist, Stuart, et al.
Publicado: (2020)

MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2017)

The evolving role of radiation in pancreatic cancer
por: Malla, Midhun, et al.
Publicado: (2023)

Manganese-free chow, a refined non-invasive solution to reduce gastrointestinal signal for T(1)-weighted magnetic resonance imaging of the mouse abdomen
por: Kersemans, Veerle, et al.
Publicado: (2019)

Improved outcome of (131)I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2017)

Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summary of the Emerald-Pancreas phase 1/expansion study located at Oxford University Hospital, UK
por: Teoh, Suliana, et al.
Publicado: (2023)

Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
por: Awad, Seifeldin, et al.
Publicado: (2020)

Prospective gating control for highly efficient cardio-respiratory synchronised short and constant TR MRI in the mouse
por: Kinchesh, Paul, et al.
Publicado: (2018)

ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway
por: Wen, Xin, et al.
Publicado: (2022)

Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration
por: Torres, Julia Baguña, et al.
Publicado: (2022)

Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer
por: Wisniewski, Luke, et al.
Publicado: (2023)

Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
por: Dréau, Didier, et al.
Publicado: (2019)

Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma
por: Trestini, Ilaria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lphjm2c5c94m6rfk0nbm2a8a9q